omega-n-methylarginine has been researched along with fenoldopam in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (fenoldopam) | Trials (fenoldopam) | Recent Studies (post-2010) (fenoldopam) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 657 | 92 | 94 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | fenoldopam (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Bos taurus (cattle) | 1.58 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brouwers, S; Dupont, AG; Massie, A; Smolders, I | 1 |
1 other study(ies) available for omega-n-methylarginine and fenoldopam
| Article | Year |
|---|---|
Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fenoldopam; Imidazoles; Indomethacin; Kidney; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes; Vasodilation; Vasodilator Agents | 2013 |